2018
DOI: 10.1093/jat/bky035
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Fentanyl and 18 Novel Fentanyl Analogs and Metabolites by LC–MS-MS, and report of Fatalities Associated with Methoxyacetylfentanyl and Cyclopropylfentanyl

Abstract: Methoxyacetylfentanyl and cyclopropylfentanyl are two of the newest illicit opioids that are infiltrating the heroin market. Methoxyacetylfentanyl and cyclopropylfentanyl were reported by the Drug Enforcement Administration (DEA) in their third quarter report of 2017 to have been chemically identified seven and five times, respectively, from drug evidence analyzed by the DEA's lab system; Q3 was the first time cyclopropylfentanyl was identified by the DEA's lab system, while methoxyacetylfentanyl was reported … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
60
0
4

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 110 publications
(66 citation statements)
references
References 8 publications
2
60
0
4
Order By: Relevance
“…In the current macaque model, a subclinical dose of radiolabeled [ 11 C]carfentanil was used to estimate RO resulting from an IM injection of naloxone. Thus, the results of this study may underestimate the dose and plasma level of NLX required to achieve a clinically significant level of RO, as very high levels of synthetic opioids have been found in overdose patients [24][25][26][27][28]. However, this study does suggest that for an invariable dose of carfentanil, increasing doses of IM NLX result in greater RO and, furthermore, increasing doses of IM NLX results in higher systemic levels.…”
Section: Discussionmentioning
confidence: 71%
“…In the current macaque model, a subclinical dose of radiolabeled [ 11 C]carfentanil was used to estimate RO resulting from an IM injection of naloxone. Thus, the results of this study may underestimate the dose and plasma level of NLX required to achieve a clinically significant level of RO, as very high levels of synthetic opioids have been found in overdose patients [24][25][26][27][28]. However, this study does suggest that for an invariable dose of carfentanil, increasing doses of IM NLX result in greater RO and, furthermore, increasing doses of IM NLX results in higher systemic levels.…”
Section: Discussionmentioning
confidence: 71%
“…butyryl fentanyl/isobutyryl fentanyl and para-fluorobutyryl fentanyl/4-fluoroisobutyryl fentanyl). Another comprehensive analytical method was proposed by Fogarty et al 54 in which fentanyl and 18 novel fentanyl analogues and metabolites were evaluated in peripheral blood by LC-MS/MS. The instrumentation consisted of a Xevo TQ-S Micro coupled with an Acquity UPLC (both from Waters).…”
Section: •2 Analytical Techniquesmentioning
confidence: 99%
“…Most are based on solid phase extraction (SPE) or liquid–liquid extraction (LLE) followed by a LC–MS/MS experiment. However, these techniques have some drawbacks: they are limited by the unavailability of reference standards (RS), 11–15 and the enrichment of the library database by the addition of new multi reaction monitoring (MRM) transitions of new compounds often requires further method optimization. Moreover, targeted screening does not allow retrospective processing of MS data to identify unknown compounds.…”
Section: Introductionmentioning
confidence: 99%